Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS
Jeanne M. Schilder, Amanda Golembesky, Tirza Areli Calderón Boyle, Gui Lan Ye, Judi Kuplast
Abstract
GENERAL COMMENTARY article Front. Pharmacol., 16 August 2023Sec. Pharmacoepidemiology Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1241524
Topics & Concepts
PharmacoepidemiologyAdverse Event Reporting SystemAdverse effectMedicinePharmacologyOncologyMedical prescriptionPharmacovigilance and Adverse Drug ReactionsAntimicrobial Resistance in StaphylococcusPARP inhibition in cancer therapy